Acta Scientific Gastrointestinal Disorders (ISSN: 2582-1091)

Review ArticleVolume 4 Issue 6

The Role of Gut Microbiota in Gastrointestinal Disease

Riddhima Banerji*

MSc in Gastroenterology, Bart's and The London School of Medicine, Queen Mary University of London

*Corresponding Author: Riddhima Banerji, MSc in Gastroenterology, Bart's and The London School of Medicine, Queen Mary University of London.

Received: March 29, 2021; Published: May 07, 2021

Citation: Riddhima Banerji. “The Role of Gut Microbiota in Gastrointestinal Disease”. Acta Scientific Gastrointestinal Disorders 4.6 (2021): 18-22.

Abstract

  Multiple studies have demonstrated that microorganisms in the gut play a key role in maintaining the normal function of the gastrointestinal tract. They are a diverse group of organisms which share an intricate relationship with the gut and one another, thereby helping to maintain a delicate physiological balance. Changes in the internal, cellular or external environment can disrupt this balance and result in pathological changes and disease. The last decade has witnessed important developments in the understanding of the role of gut microbiota in the genesis of gastrointestinal disease. The recent pandemic has underscored their significant function. Therefore, it is vital that research in this crucial area continues.

Keywords: Gut Microbiota; Gastrointestinal Disease; Gastrointestinal Tract

Bibliography

  1. Beatty JK., et al. “Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection”. World Journal of Gastroenterology 20 (2014): 3976-3985.
  2. Chow J., et al. “Pathobionts of the gastrointestinal microbiota and inflammatory disease”. Current Opinion in Immunology 23 (2011): 473-480.
  3. Couturier-Maillard A., et al. “NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer”. Journal of Clinical Investigation 123 (2013): 700-711.
  4. Devkota S., et al. “Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice”. Nature 487 (2012): 104-108.
  5. Frank DN., et al. “Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases”. Proceedings of the National Academy of Sciences of the United States of America 104 (2007): 13780-13785.
  6. Galipeau HJ., et al. “Intestinal microbiota modulates gluten-induced immunopathology in humanized mice”. The American Journal of Pathology 185 (2015): 2969-2982.
  7. Gianotti L., et al. “A randomized double blind trial on perioperative administration of probiotics in colorectal cancer patients”. World Journal of Gastroenterology 16 (2010): 167-175.
  8. Hentges DJ., et al. “Effect of a high-beef diet on the fecal bacterial flora of humans”. Cancer Research 37 (1977): 568-571.
  9. Igarashi M., et al. “Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia”. BMJ Open Gastroenterology (2017).
  10. Ishikawa H., et al. “Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors”. International Journal of Cancer 116 (2005): 762-767.
  11. Kim G., et al. “Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath”. Digestive Diseases and Sciences 57 (2012): 3213-3218.
  12. Kronman MP., et al. “Antibiotic exposure and IBD development among children: a population-based cohort study”. Pediatrics 130 (2012): e794-e803.
  13. Lucke K., et al. “Prevalence of Bacteroides and Prevotella in ulcerative colitis”. Journal of Medical Microbiology 55 (2006): 617-624.
  14. Manichanh C., et al. “The gut microbiota in IBD”. Nature Reviews Gastroenterology and Hepatology 9 (2012): 599-608.
  15. Mårild K., et al. “Antibiotic exposure and the development of coeliac disease: a nationwide case-control study”. BMC Gastroenterology 13 (2013): 109.
  16. , et al. “Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment”. Genome Biology 13 (2012): R79.
  17. Mukherjee PK., et al. “Microbiota in gastrointestinal diseases”. Nature Reviews Gastroenterology and Hepatology 12 (2015): 77-87.
  18. Nagao-Kitamoto H., et al. “Pathogenic role of the gut microbiota in gastrointestinal disease”. Intestinal Research 14 (2016): 127-138.
  19. Nakae H., et al. “Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt”. BMJ Open Gastroenterology (2016).
  20. Öhman L., et al. “Crosstalk at the mucosal border: importance of the gut microenvironment in IBS”. Nature Reviews Gastroenterology and Hepatology 12 (2015): 36-49.
  21. Olivares M., et al. “Human milk composition differs in healthy mothers and mothers with celiac disease”. European Journal of Nutrition 54 (2015): 119-128.
  22. Rautava S., et al. “Microbial contact during pregnancy, intestinal colonization and human disease”. Nature Reviews Gastroenterology and Hepatology 9 (2012): 565-576.
  23. Rhee KJ., et al. “Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice”. Infection and Immunity 77 (2009): 1708-1718.
  24. Rowan F., et al. “Desulfovibrio bacterial species are increased in ulcerative colitis”. Diseases of the Colon and Rectum 53 (2010): 1530-1536.
  25. Rubinstein MR., et al. “Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/b-catenin signaling via its FadA adhesin”. Cell Host and Microbe 14 (2013): 195-206.
  26. Sadlack B., et al. “Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene”. Cell 75 (1993): 253-261.
  27. Sánchez E., et al. “Duodenal-mucosal bacteria associated with celiac disease in children”. Applied and Environmental Microbiology 79 (2013): 5472-5479.
  28. Sellon RK., et al. “Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice”. Infection and Immunity 66 (1998): 5224-5231.
  29. Shaw SY., et al. “Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease”. The American Journal of Gastroenterology 105 (2010): 2687-2692.
  30. Sokol H., et al. “Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients”. Proceedings of the National Academy of Sciences of the United States of America 105 (2008): 16731-16736.
  31. Van Nood E., et al. “Duodenal infusion of donor feces for recurrent Clostridium difficile”. The New England Journal of Medicine 368 (2013): 407-415.
  32. Wright DP., et al. “Prevotella enzymes involved in mucin oligosaccharide degradation and evidence for a small operon of genes expressed during growth on mucin”. FEMS Microbiology Letters 190 (2000): 73-79.
  33. Zhang C., et al. “Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations”. The ISME Journal 6 (2012): 1848-1857.

Copyright: © 2021 Riddhima Banerji. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US